Volume 27, Number 3—March 2021
Research
Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May–July 2020
Samira Sami
, Lara J. Akinbami, Lyle R. Petersen, Addie Crawley, Susan L. Lukacs, Don Weiss, Rebecca A. Henseler, Nga Vuong, Lisa Mackey, Anita Patel, Lisa A. Grohskopf, Beth Maldin Morgenthau, Demetre Daskalakis, and Preeti Pathela
, Lara J. Akinbami, Lyle R. Petersen, Addie Crawley, Susan L. Lukacs, Don Weiss, Rebecca A. Henseler, Nga Vuong, Lisa Mackey, Anita Patel, Lisa A. Grohskopf, Beth Maldin Morgenthau, Demetre Daskalakis, and Preeti Pathela
Table
Percentage of respondents who were seropositive for SARS-CoV-2 IgG, by demographic and health characteristics, in a study of first responders and public safety personnel, New York City, New York, USA, May 18–July 2, 2020*
| Characteristic | No. (%) |
% Seropositive (95% CI) |
||
|---|---|---|---|---|
| Total |
22,647 (100.0) |
22.5 (21.9–23.0) |
||
| Sex | ||||
| M | 17,118 (75.6) | 21.9 (21.3–22.5) | ||
| F |
5,529 (24.4) |
24.2 (23.1–25.4) |
||
| Age group, y | ||||
| 18–24 | 795 (3.5) | 32.0 (28.7–35.3) | ||
| 25–34 | 6,677 (29.5) | 26.4 (25.3–27.5) | ||
| 35–44 | 8,034 (35.5) | 20.2 (19.4–21.1) | ||
| 45–59 | 6,328 (27.9) | 20.3 (19.4–21.4) | ||
| 60–64 | 589 (2.6) | 20.7 (17.5–24.2) | ||
| >65 |
224 (1.0) |
18.3 (13.5–24.0) |
||
| Race/ethnicity | ||||
| Non-Hispanic White | 10,013 (44.2) | 18.5 (17.7–19.2) | ||
| Non-Hispanic Black | 3,292 (14.5) | 30.1 (28.5–31.7) | ||
| Non-Hispanic Asian | 1,647 (7.3) | 21.3 (19.4–23.4) | ||
| Hispanic or Latino | 5,460 (24.1) | 26.9 (25.7–28.1) | ||
| Non-Hispanic other race† | 548 (2.4) | 20.3 (17.0–23.9) | ||
| Decline to answer |
1,687 (7.5) |
19.3 (17.4–21.2) |
||
| Weight status, n = 22,632‡ | ||||
| Underweight or normal weight | 4,048 (17.9) | 21.4 (20.2–22.7) | ||
| Overweight | 10,386 (45.9) | 22.1 (21.3–22.9) | ||
| Obese | 7,500 (33.1) | 23.1 (22.1–24.1) | ||
| Severely obese |
698 (3.1) |
27.8 (24.5–31.3) |
||
| Housing, n = 22,641 | ||||
| Single family | 15,455 (68.3) | 21.1 (20.5–21.8) | ||
| Multiunit |
7,186 (31.7) |
25.3 (24.3–26.4) |
||
| Residence borough | ||||
| Outside New York City | 8,654 (38.2) | 18.3 (17.5–19.2) | ||
| Bronx | 1,948 (8.6) | 28.8 (26.8–30.9) | ||
| Brooklyn | 3,329 (14.7) | 28.0 (26.5–29.5) | ||
| Manhattan | 1,207 (5.3) | 21.4 (19.1–23.8) | ||
| Queens | 4,834 (21.3) | 25.4 (24.2–26.6) | ||
| Staten Island |
2,675 (11.8) |
19.8 (18.3–21.3) |
||
| Workplace§ | ||||
| Correctional facility | 1,272 (5.6) | 36.2 (33.6–39.0) | ||
| Emergency medical services | 2,418 (10.7) | 35.2 (33.3–37.2) | ||
| Childcare setting (Regional Enrichment Center) | 677 (3.0) | 21.3 (18.2–24.6) | ||
| Fire services | 6,087 (26.9) | 20.8 (19.8–21.9) | ||
| Police department | 11,885 (52.5) | 19.8 (19.1–20.5) | ||
| Medical examiner office |
394 (1.7) |
11.7 (8.7–15.3) |
||
| Workplace borough | ||||
| Bronx | 3,524 (15.6) | 26.8 (25.4–28.3) | ||
| Brooklyn | 6,075 (26.8) | 24.1 (23.1–25.2) | ||
| Manhattan | 5,755 (25.4) | 19.7 (18.6–20.7) | ||
| Queens | 6,200 (27.4) | 21.9 (20.9–23.0) | ||
| Staten Island |
1,093 (4.8) |
17.4 (15.2–19.8) |
||
| Exposure to persons who tested positive for SARS-CoV-2‡ | ||||
| Household member | 2,393 (10.6) | 48.3 (46.3–50.3) | ||
| Coworker | 14,912 (65.9) | 23.7 (23.0–24.3) | ||
| Patient | 6,502 (28.7) | 26.9 (25.8–28.0) | ||
| Other person | 7,721 (34.1) |
26.8 (25.8–27.8) |
||
*BMI, body mass index; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. †Non-Hispanic other race includes Native Hawaiian and other Pacific Islander and American Indian and Alaska Native. ‡Weight status categories defined as underweight or normal weight (BMI <25), overweight (BMI >25 but <30), obese (BMI >30 but <40), and severely obese (BMI >40). §Workplace and self-reported exposure to persons who tested positive for SARS-CoV-2 are not mutually exclusive.
Page created: January 11, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.